Farma Kian | Kian Sector Fund - B price, AI-powered analysis and sentiment

The positive news is that the growth in profitability and stock returns in the pharmaceutical sector indicates an improvement in operational performance.

Jul 28, 2026

All Farma Kian News

nets

3-years Comparison

nets

Financial Stats

29,846.0

NAV

0.986

P/NAV

411.0

NAV-P

1,042,391,942,528

Today's Trade Value

35,844,710

Today's Trade Volume

51,224,818

30-Day Average Trade Volume

Performance Overview

1-Week Return

6.86%

1-Month Return

22.99%

1-Year Return

206.04%

5-Year Return

194.35%

Chart Analysis (AI)

Saham has demonstrated exceptional short-term performance, with a 1-week return of 11.25% and a 1-month return of 14.05%. The funds momentum is further highlighted by its 3-month return of 75.9% and 6-month return of 69.04%. The 1-year return of 132.7% indicates strong long-term growth potential. These returns suggest effective management and strategic investment decisions, making Saham an attractive option for investors seeking high growth. However, such rapid growth may also indicate potential volatility, warranting careful consideration.

Saham

85,233 IRR

Samin has demonstrated exceptional performance with a 1-year return of 141.23%, significantly outpacing shorter-term gains. The 3-month and 6-month returns of 74.67% and 72.21%, respectively, highlight consistent momentum. Recent 1-week and 1-month returns of 5.24% and 14.48% suggest sustained growth. This strong performance across all timeframes indicates effective management and robust market positioning. However, such high returns may raise concerns about sustainability. Investors should monitor for potential volatility.

Samin

68,680 IRR

Rakhsh has demonstrated exceptional performance across all trailing return periods, with a 1-week return of 8.97%, 1-month return of 22.36%, and a remarkable 1-year return of 92.81%. The funds momentum is evident in its 3-month and 6-month returns of 46.98% and 30.0%, respectively. Such consistent and high returns suggest strong management and effective investment strategies. However, investors should be cautious of potential volatility and ensure the fund aligns with their risk tolerance and long-term goals.

Rakhsh

26,500 IRR

Javahers recent performance shows mixed signals. While the 1-year return of 137.91% is impressive, shorter-term returns are concerning. The fund has experienced negative returns over the past 3 months (-5.48%) and 6 months (-3.5%), indicating recent underperformance. The 1-week and 1-month returns are positive (1.81% and 4.88%), but not enough to offset the recent decline. This inconsistency suggests potential volatility and uncertainty in the funds strategy.

Javaher

69,100 IRR

Ganjs recent performance shows mixed signals. While the 1-year return of 140.43% is impressive, short-term returns are concerning. The fund has experienced negative returns over the past 3 and 6 months, indicating potential recent underperformance. The 1-week and 1-month returns are positive but relatively modest. This inconsistency suggests volatility and uncertainty in the funds strategy. Investors should carefully consider the recent downturn before making decisions.

Ganj

158,700 IRR

Zarfams recent performance shows mixed results. While the 1-year return of 135.11% is impressive, short-term returns are concerning. The fund has experienced negative returns over the past 3 and 6 months, indicating potential volatility or a recent downturn. The 1-week and 1-month returns are positive but not enough to offset the recent losses. This inconsistency suggests that the funds management may be struggling to maintain consistent growth, warranting caution for potential investors.

Zarfam

136,880 IRR

Sarvats recent performance shows exceptional short-term gains, with a 124.21% return over 3 months and 146.63% over 6 months. The 1-year return of 109.35% is also impressive, indicating strong momentum. However, the 1-week return of 0.0% suggests a recent pause in growth. While the fund has demonstrated robust performance, the lack of recent movement warrants caution. Investors should monitor whether this pause is temporary or a sign of slowing momentum before making further decisions.

Sarvat

2,240,048 IRR

Sarvat Saz has demonstrated exceptional short-term performance, with a 9.11% return over the past week and 22.16% over the past month. The funds momentum is further highlighted by its 49.86% return over the past three months and 44.87% over six months. Its one-year return of 86.59% is particularly impressive, indicating strong management and strategic investment decisions. However, such high short-term gains may not be sustainable, and investors should assess the funds long-term strategy and risk management.

Dara Yekom has shown impressive short-term performance, with a 12.52% return over the past week and a 66.47% return over the past three months. The funds one-year return of 93.09% is particularly notable, indicating strong long-term growth. However, the one-month return of 0.15% suggests a recent slowdown. While the funds historical performance is strong, investors should monitor whether this momentum can be sustained, especially given the recent deceleration.

Dara Yekom

472,207 IRR

Hamta has demonstrated exceptional performance across all trailing return periods, with a remarkable 100.63% 1-year return and impressive short-term gains of 7.75% (1-week), 11.52% (1-month), 70.04% (3-month), and 64.47% (6-month). These returns significantly outperform market averages, indicating strong management and strategic investment decisions. The funds consistent growth suggests robust risk management and effective market positioning, making it a standout choice for investors seeking high returns.

Sanas recent performance shows exceptional short-term gains, with a 1-week return of 11.74% and a 1-month return of 22.47%. The 3-month and 6-month returns are also impressive at 78.71% and 73.35%, respectively. The 1-year return of 139.15% indicates strong long-term growth. However, such high short-term returns may not be sustainable, suggesting potential volatility. Investors should consider whether this performance aligns with their risk tolerance and investment goals.

Sana

45,500 IRR

Homans recent performance shows impressive short-term gains, with a 9.18% return over the past week and 43.22% over the past three months. The funds one-year return of 106.12% is particularly notable, indicating strong growth. However, the six-month return of 38.88% suggests a slight slowdown in momentum. While the fund has demonstrated robust performance, investors should monitor whether this growth is sustainable or if it reflects short-term market fluctuations. The funds management appears effective, but caution is advised.

Homan

24,807 IRR

Farma Kian has demonstrated exceptional performance across all trailing return periods, with a remarkable 195.63% 1-year return and triple-digit returns over 3 and 6 months. The funds short-term momentum is also strong, evidenced by its 18.81% 1-month and 5.14% 1-week returns. This consistent outperformance suggests robust management and strategic investment decisions, potentially capitalizing on favorable market conditions or specific sector opportunities. However, such high returns may raise concerns about sustainability and potential volatility.

Farma Kian

29,150 IRR

Talas recent performance shows mixed signals. While the 1-year return of 136.99% is impressive, short-term returns are concerning. The 3-month and 6-month returns are both negative, indicating recent underperformance. The 1-week and 1-month returns are positive but relatively modest. This suggests potential volatility and a possible shift in trend. Investors should closely monitor Talas performance and consider the recent downturn before making investment decisions.

Tala

1,313,977 IRR

Samans recent performance shows impressive short-term gains, with a 5.93% return over the past week and 13.03% over the past month. The fund has also demonstrated strong momentum over the past three and six months, with returns of 62.63% and 65.06%, respectively. The one-year return of 78.1% is particularly notable, indicating consistent long-term growth. However, such high short-term returns may not be sustainable, and investors should monitor for potential volatility.

Hamoons recent performance shows impressive short-term gains, with a 7.8% weekly and 10.48% monthly return. The 3-month and 6-month returns of 62.28% and 57.72%, respectively, indicate strong momentum. However, the 1-year return of 112.48% suggests potential overvaluation or unsustainable growth. While the fund has performed exceptionally well in the short term, investors should be cautious about the long-term sustainability of these returns and consider potential market corrections.

Hamoon

23,650 IRR

Kian Sector Fund - B

Statistical info

Financial Stats

News

Latest News

nets

Analytical info

3-years Comparison

nets

Financial Stats

Performance Overview